Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.09 USD -6.77% Market Closed
Market Cap: 541.7m USD
Have any thoughts about
Phathom Pharmaceuticals Inc?
Write Note

Phathom Pharmaceuticals Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Phathom Pharmaceuticals Inc
Total Liabilities & Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Total Liabilities & Equity
$413.8m
CAGR 3-Years
12%
CAGR 5-Years
241%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Liabilities & Equity
$178.3B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Liabilities & Equity
$93.7B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Total Liabilities & Equity
$216.2B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Total Liabilities & Equity
$117.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Total Liabilities & Equity
$75.6B
CAGR 3-Years
16%
CAGR 5-Years
15%
CAGR 10-Years
8%

See Also

What is Phathom Pharmaceuticals Inc's Total Liabilities & Equity?
Total Liabilities & Equity
413.8m USD

Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Total Liabilities & Equity amounts to 413.8m USD.

What is Phathom Pharmaceuticals Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
241%

Over the last year, the Total Liabilities & Equity growth was 151%. The average annual Total Liabilities & Equity growth rates for Phathom Pharmaceuticals Inc have been 12% over the past three years , 241% over the past five years .

Back to Top